Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,447 signal articles · 187 in last 24h · 121,672 total before filter · latest 11m ago
187last 24h
1273last 7d
214● bullish (7d)
152● bearish (7d)
205publishers
AllMacro210Earnings441M&A101Regulatory26Product9Analyst13
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
IDEX’s (NYSE:IEX) Q2 CY2026 Sales Beat Estimates, Provides Encouraging Guidance
StockStory23d agobullish
IDEX’s (NYSE:IEX) Q2 CY2026 Sales Beat Estimates, Provides Encouraging Guidance

Manufacturing company IDEX (NYSE:IEX) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter’s revenue was optimistic at $931.4 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $2.32 per share was 10.1% above analysts’ consensus estimates.

Procter & Gamble Earnings Beat Estimates. This Warning Is Pressuring the Stock.
Barrons.com23d agobullish
Procter & Gamble Earnings Beat Estimates. This Warning Is Pressuring the Stock.

Shares of Procter & Gamble declined in premarket trading Wednesday as Wall Street reacted to mixed quarterly earnings and underwhelming profit guidance from the consumer packaged goods company. Procter & Gamble posted core earnings of $1.43 a share for the fiscal fourth quarter, down from $1.48 a year ago but slightly above Wall Street expectations of $1.41. It was a mixed bag for Procter & Gamble’s product categories—which range from baby care to hair care.

Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations
StockStory23d agobearish
Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations

Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.5% year on year to $5.44 billion. On the other hand, next quarter’s revenue guidance of $5.27 billion was less impressive, coming in 2.2% below analysts’ estimates. Its non-GAAP profit of $0.86 per share was 3.8% above analysts’ consensus estimates.

United Microelectronics Q2 Earnings Call Highlights
MarketBeat23d agoneutral
United Microelectronics Q2 Earnings Call Highlights

United Microelectronics (NYSE:UMC) reported higher second-quarter revenue, wafer shipments and utilization as demand strengthened in communications and consumer applications, while the company raised its 2026 capital-expenditure budget to support silicon photonics and advanced-packaging growth initi